Pathologic Response after Neoadjuvant Chemoradiotherapy versus Chemoimmunotherapy in Driver-Negative Stage III-N2 Non-Small Cell Lung Cancer

Junghee Lee1, Dong Young Jeong2, JeongA Son1, Yeong Jeong Jeon1, Seong Yong Park1, Jong Ho Cho1, Yong Soo Choi1, Ho Yun Lee2, Hong Kwan Kim1 1. Division of Thoracic Surgery, Department of Thoracic and Cardiovascular surgery, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea 2. Department of Radiology and Center for Imaging Science, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea

첨부파일 : Abstract_KTCVS2025_nCI driver-nagative.pdf

책임저자: Hong Kwan Kim

성균관대학교 삼성서울병원

발표자: Junghee Lee, E-mail : ts.junghee@gmail.com